{
    "id": 19875,
    "fullName": "SEM1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "SEM1 over exp indicates an over expression of the Sem1 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 7979,
        "geneSymbol": "SEM1",
        "terms": [
            "SEM1",
            "C7orf76",
            "DSS1",
            "ECD",
            "SHFD1",
            "Shfdg1",
            "SHFM1",
            "SHSF1"
        ]
    },
    "variant": "over exp",
    "createDate": "03/18/2016",
    "updateDate": "04/07/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5216,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, overexpression of Sem1 in breast cancer cells resulted in decreased sensitivity to camptothecin in culture (PMID: 24289229).",
            "molecularProfile": {
                "id": 20303,
                "profileName": "SEM1 over exp"
            },
            "therapy": {
                "id": 3397,
                "therapyName": "Camptothecin",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4919,
                    "pubMedId": 24289229,
                    "title": "Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24289229"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20303,
            "profileName": "SEM1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}